Friday, October 20, 2023 10:59:08 AM
Recent ICU News
- FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis • GlobeNewswire Inc. • 11/06/2024 02:00:00 PM
- Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial • GlobeNewswire Inc. • 11/01/2024 12:30:00 PM
- SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE • GlobeNewswire Inc. • 10/31/2024 12:30:00 PM
- Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update • GlobeNewswire Inc. • 10/25/2024 03:32:00 PM
- Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 • GlobeNewswire Inc. • 10/25/2024 12:30:00 PM
- SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial • GlobeNewswire Inc. • 10/23/2024 12:30:00 PM
- SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers • GlobeNewswire Inc. • 10/22/2024 12:30:00 PM
- SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis • GlobeNewswire Inc. • 10/18/2024 12:30:00 PM
- SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week • GlobeNewswire Inc. • 10/15/2024 12:30:00 PM
- SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit • GlobeNewswire Inc. • 10/09/2024 12:30:00 PM
- SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities • GlobeNewswire Inc. • 10/08/2024 12:30:00 PM
- SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial • GlobeNewswire Inc. • 09/25/2024 12:30:00 PM
- SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- September 6, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against ICU • PR Newswire (US) • 09/05/2024 09:45:00 AM
- SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt • GlobeNewswire Inc. • 09/04/2024 12:30:00 PM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of SeaStar Medical Holding Corporation(ICU) Shareholders • PR Newswire (US) • 08/29/2024 09:45:00 AM
- Shareholders that lost money on SeaStar Medical Holding Corporation(ICU) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 08/26/2024 09:45:00 AM
- SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/22/2024 09:45:00 AM
- Shareholders of SeaStar Medical Holding Corporation Should Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/19/2024 09:45:00 AM
- SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before September 6, 2024 to Discuss Your Rights - ICU • PR Newswire (US) • 08/15/2024 09:45:00 AM
- SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 08/13/2024 08:38:00 PM
- The Gross Law Firm Notifies SeaStar Medical Holding Corporation Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 08/08/2024 09:45:00 AM
- Class Action Filed Against SeaStar Medical Holding Corporation (ICU) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 08/05/2024 09:45:00 AM
- Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s • GlobeNewswire Inc. • 07/26/2024 01:00:00 PM
- First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s FDA-Approved QUELIMMUNE Therapeutic Device • GlobeNewswire Inc. • 07/23/2024 12:30:00 PM
FEATURED DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • Nov 7, 2024 2:16 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • Nov 7, 2024 8:48 AM
FEATURED SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • Nov 7, 2024 7:00 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM